Relationship between glycated hemoglobin and blood glucose levels in fasting and two hours after 75 g oral glucose in gestational diabetes mellitus


  • Avinash N. Jadhao Department of Biochemistry, Seth GSMC and KEMH, Parel, Mumbai, Maharashtra, India
  • Shubhada G. Vengurlekar 45 BDD Municipal Dispensary G South, Mumbai, Maharashtra, India
  • Meeta P. Shah Bai Gulbai Municipal Dispensary G North, Mumbai, Maharashtra, India
  • Santosh S. Pathare Department of Physiology, Seth GSMC and KEMH, Parel, Mumbai, Maharashtra, India



HbA1c, Gestational diabetes mellitus, Marker


Background: Oral glucose tolerance test (OGTT) performed at 24-28 weeks gestation is the current recommended method to the diagnosis of gestational diabetes mellitus (GDM). Many recent studies investigating glycated hemoglobin (HbA1c) in detecting GDM yield different results. There are no published data on HbA1c in the diagnosis of GDM in India.

Methods: A cross-sectional study was carried out at T.N.M.C. Mumbai during the period from January to June 2021 to assess the reliability of HbA1c in the diagnosis of GDM.

Results: We included 397 pregnant females. The age range of the patients was 18 to 35 years, with a mean of 24.57±11.10 years. The mean fasting blood glucose level was 129.73 mg/dl and the mean 2 hours after 75 g oral glucose level was 188.21 mg/dl. The difference between the two was statistically significant. The Spearman's correlation coefficient (r) between fasting blood glucose and HbA1c was 0.610 (p<0.05) and between postprandial blood glucose and HbA1c was 0.683 (p<0.05). Scatter plots of FBG and 2 hours after 75 g oral glucose with HbA1C shows a positive correlation.

Conclusions: This study showed that 2 hours after 75 g oral glucose had a better correlation with HbA1c than fasting blood glucose level. In the absence of HbA1c facility or unreliable HbA1c report, postprandial blood glucose can be a surrogate marker of HbA1c for management and monitoring of gestational diabetes mellitus, but a larger study is needed to confirm this finding.


Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care. 2007;30(Suppl. 2), S251-S260.

Association AD, Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31(1):S61-78.

Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS, et al. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care. 2005;28(3):579-84.

HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991-2002.

Zhu Y, Zhang C. Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr Diab Rep. 2016;16(1):7.

International Expert Committee TIE. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327-34.

Hughes RCE, Moore MP, Gullam JE, Mohamed K, Rowan J. An early pregnancy HbA1c≥5.9% (41mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes. Diabetes Care. 2014;37(11).2953-9.

Gold AE, Reilly R, Little J, Walker JD. The effect of glycemic control in the pre-conception period and early pregnancy on birth weight in women with IDDM. Diabetes Care. 1998;21(4):535-8.

Kerssen A, de Valk HW, Visser GHA. Sibling birthweight as a predictor of macrosomia in women with type 1 diabetes. Diabetologia. 2005;48(9):1743-8.

Renz PB, Cavagnolli G, Weinert LS, Silveiro SP, Camargo JL. HbA1c test as a tool in the diagnosis of gestational diabetes mellitus. PLoS One. 2015;10(8):e0135989.

Khalafallah A, Phuah E, Al-Barazan AM, Nikakis I, Radford A, Clarkson W, et al. Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus. BMJ Open. 2016;6(4):e011059.

Kwon SS, Kwon JY, Park YW, Kim YH, Lim JB. HbA1c for diagnosis and prognosis of gestational diabetes mellitus. Diabetes Res Clin Pract. 2015;110(1):38-43.

Siricharoenthai P, Phupong V. Diagnostic accuracy of HbA1c in detecting gestational diabetes mellitus. J Matern Neonatal Med. 2019;1-4.

Dubey D, Kunwar S, Gupta U. Mid-trimester glycosylated hemoglobin levels (HbA1c) and its correlation with oral glucose tolerance test (World Health Organization 1999). J Obstet Gynaecol Res. 2019;45(4):817-23.

Evers IM, De Valk HW, Mol BW, Ter Braak EW, Visser GHA. Macrosomia despite good glycaemic control in Type I diabetic pregnancy; results of a nationwide study in The Netherlands. Diabetologia. 2002;45(11):1484-9.

Sevket O, Sevket A, Ozel A, Dansuk R, Kelekci S. The use of HbA1c as an aid in the diagnosis of gestational diabetes mellitus. J Obstet Gynaecol (Lahore). 2014;34(8):690-2.

Maesa J-M, Fernandez-Riejos P, Gonzalez-Rodriguez C, Sanchez Margalet V. Screening for gestational diabetes mellitus by measuring glycated hemoglobin can reduce the use of the glucose challenge test. Ann Lab Med. 2019;39(6):524.

Ye M, Liu Y, Cao X, Yao F, Liu B, Li Y, et al. The utility of HbA1c for screening gestational diabetes mellitus and its relationship with adverse pregnancy outcomes. Diabetes Res Clin Pract. 2016;1(114):43-9.

Rajput R, Yogesh Yadav RM, Nanda S. Utility of HbA 1c for diagnosis of gestational diabetes mellitus. Diabetes Res Clin Pract. 2012;98(1):104-7.

Renz PB, Chume FC, Timm JRT, Pimentel AL, Camargo JL. Diagnostic accuracy of glycated hemoglobin for gestational diabetes mellitus: a systematic review and meta-analysis. Clin Chem Lab Med. 2019;57(10):1435-49.

Ryu AJ, Moon HJ, Na JO, Kim YJ, Kim SJ, Mo SI, et al. The usefulness of the glycosylated hemoglobin level for the diagnosis of gestational diabetes mellitus in the Korean population. Diabetes Metab J. 2015;39(6):507-11.

Radin MS. Pitfalls in Hemoglobin A1c Measurement: When Results may be Misleading. J Gen Intern Med. 2013;29(2):388-94.

Rosediani M, Azidah AK, Mafauzy. Correlation between fasting plasma glucose, postprandial glucose and glycated haemoglobin and fructosamine. Med J Malaysia. 2006;61(1):67-71.

Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. Australasian Med J. 2014;7(1):45-8.

Macaulay S, Ngobeni M, Dunger DB, Norris SA. The prevalence of gestational diabetes mellitus amongst black South African women is a public health concern. Diabetes Res Clin Pract. 2018;139:278-87.

World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: World Health Organization Guideline. Diabetes Res Clin Pract. 2014;103(3):341-63.

Law GR, Gilthorpe MS, Secher AL, Temple R, Bilous R, Mathiesen ER, et al. Translating HbA1c measurements into estimated average glucose values in pregnant women with diabetes. Diabetologia. 2017;60(4):618-24.

Bleyer AJ, Hire D, Russell GB, Xu J, Divers J, Shihabi Z, Xu J, Divers J, Shihabi Z, et al. Ethnic variation in the correlation between random serum glucose concentration and glycated haemoglobin. Diabet Med. 2009;26(2):128-33.

Grimsby JL, Porneala BC, Vassy JL, Yang Q, Florez JC, Dupuis J, et al. Race-ethnic differences in the association of genetic loci with HbA1c levels and mortality in U.S. adults: the third National Health and Nutrition Examination Survey (NHANES III). BMC Med Genet. 2012;27(13):30.

Walker AR, Caughey AB. Positivity thresholds of HbA1c assay as a screening test for diabetes mellitus in the first trimester in highrisk populations. J Matern Neonatal Med. 2020;9:1-5.






Original Research Articles